DDev Plastiks (DDEVPLSTIK)

FairStock Score: 55/100 — STEADY

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Strong ROE of 27.02% and ROCE of 33.92% demonstrate excellent capital efficiency
• Very low debt/equity of 0.05 provides a rock-solid balance sheet
• Piotroski F-score of 7/9 indicates robust financial health
• High promoter holding of 75% ensures management alignment with minority shareholders
• Sales growth of 10.91% shows the business is expanding

Concerns

• Profit growth of only 3.09% lags far behind sales growth, signaling margin pressure
• PEG ratio of 2.01 suggests the stock is not cheap relative to its growth rate
• Dividend yield is negligible at 0.65%, offering little income support
• Stock trades 33% below its 52-week high; could indicate a value trap or an opportunity depending on fundamentals

AI Analysis

When I look at DDev Plastiks, I see a specialty chemicals business with the kind of balance sheet that makes a value investor smile. Earning 27% on equity and 33.9% on capital employed, with debt at just 0.05 times equity, this is a company that is putting its shareholders' money to excellent work. The Piotroski F-score of 7/9 further confirms a sound financial position, and a promoter holding of 75% shows owners are heavily invested alongside us. Sales grew a respectable 10.91%, but profit growth lagged at only 3.09% – that gap bothers me. If margins are under pressure, today's earnings power may not be as strong as the ROE suggests. At ₹242.75, I'm paying 14.09 times earnings and 3.38 times book value. For a company with modest profit growth, that PEG of 2.01 tells me I'm not getting a bargain. The stock has fallen from a 52-week high of ₹360, offering some cushion, but a 0.65% dividend yield means I'm not paid generously to wait. Graham would say: interesting business, but insufficient margin of safety. I admire the low debt and high returns, which hint at a niche moat in specialty chemicals. Yet, I need to see profit growth catch up with sales growth before I commit real capital. This is a good business – maybe an excellent one – but the price must match the reality. I'd let the earnings prove themselves in the coming quarters, keeping a close watch on margins and capital allocation. If the stock gets cheaper while fundamentals remain intact, this could become a very attractive investment. For now, I'd rather observe than act. The numbers just don't scream 'buy' yet.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer